Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
when used in combination with other drugs these UGT inhibitors act to significantly enhance efficacy antiviral therapeutics that require UGT's for their systemic clearance. More
Clinical identification of a new disease termed "isolated micronodular adrenocortical disease" (iMAD), as well as the role of PDE11A gene in this disease More
Related Reports
Market Research Reports provided by reports.iptechex.com
Oct 2011 - 41 pages - $500
Dec 2010 - 93 pages - $500
Nov 2010 - 20 pages - $125
Nov 2010 - 36 pages - $500
Sep 2011 - 66 pages - $500
Dec 2010 - 15 pages - $500
Dec 2010 - 25 pages - $500
Mar 2011 - 26 pages - $250
Dec 2010 - 16 pages - $500
Feb 2011 - 36 pages - $500
Your selection
Browse By
- Therapeutic target
- Amenorrahea
- Androgen deficiency
- Endocrine system
- Estrogen replacement
- Growth disorders
- Hormonal disorder (other)
- Hormone replacement therapy
- Hurler's syndrome
- Hypogonadism
- Hypothalamic
- Menopause
- Pancreatic exocrine insufficiency
- Sex hormone (other)
- Testosterone replacement
- Thyroid disorders
- Turner's syndrome
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us